Skip to content

Northern Alberta Psychosocial Telecare (NAPT) Screening for HNC Patients

Northern Alberta Psychosocial Telecare (NAPT) Screening for Surgical Head and Neck Cancer Patients: a Randomized Controlled Trial

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03215199
Acronym
NAPT
Enrollment
9
Registered
2017-07-12
Start date
2017-09-01
Completion date
2020-06-30
Last updated
2026-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Distress

Brief summary

This is a randomized controlled trial comparing a web-based psychosocial screening application to usual care in a cohort of surgically-treated head and neck cancer patients to determine its efficacy in monitoring depression and distress, and prompting necessary psychiatry/psychology referrals. In addition, treatment adherence, rehabilitation and return to work, primary care utilization, and survival will be monitored.

Detailed description

This is a randomized controlled trial comparing a web-based psychosocial screening application to usual care in a cohort of surgically-treated head and neck cancer patients. This study will utilize a web-based application available on desktop or laptop computers, and smartphones. The application involves monitoring using the NCCN Distress Thermometer Score, the Quick Inventory of Depressive Symptomatology-Self Report (QIDS-SR) score, and the Head and Neck Research Network (HNRN-33), a patient-reported, validated functional outcomes score. These assessments will be completed at baseline, 2 weeks postoperatively, and monthly thereafter until 12 months. Patients will have the option of filling out questionnaires more frequently if desired. This web-based application, the NAPT App, will allow patients to alert the treatment team of their current state of mood or distress. Automatic alerts will be sent to the team if a Distress Score of \</=3, a QIDS score \>/=11, or suicidal ideation are expressed in the application. The study duration will be 12 months with a primary endpoint of 6 months. Our primary outcome will be NCCN Distress Thermometer Score at 6 months, with secondary outcomes of the QIDS and HNRN-33 functional scores at 6 and 12 months. Additional outcomes assessed will pertain to completion of adjuvant therapy, weight maintenance, rehabilitation and return to work, and survival. Health services delivery outcomes, such as primary care visits, emergency department visits, hospitalizations, and narcotic use will also be evaluated.

Interventions

OTHERNAPT

Web-based depression and distress monitoring application

Sponsors

University of Alberta
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years * New (non-recurrent) head and neck cancer * Primary surgical treatment

Exclusion criteria

* \<18 years * Recurrent head and neck cancer * Previous chemotherapy or radiation therapy * History of psychiatric or psychologic illness * History of previous cancers or cancer distress

Design outcomes

Primary

MeasureTime frameDescription
Distress Thermometer Score6 monthsNCCN Distress Thermometer Score

Secondary

MeasureTime frameDescription
QIDS Score6 and 12 monthsQuick Inventory of Depressive Symptomatology-Self Report (QIDS-SR)
HNRN-336 and 12 monthsHead and Neck Research Network (HNRN-33)
Completion of Adjuvant Therapy6 monthsCompletion of Adjuvant Therapy, including radiation or chemotherapy
Return to work12 monthsReturn to work by 12 months
Hospital Readmissions12 monthsHospital Readmissions
Primary Care Visits12 monthsPrimary Care Visits to Family Physician
Emergency Department Visits12 monthsEmergency Department Visits

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 15, 2026